COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    MTT 15-384
Previous Study | Return to List | Next Study

Matched Targeted Therapy For High-Risk Leukemias and MDS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02670525
Recruitment Status : Suspended (Temporarily closed for interim data analysis.)
First Posted : February 1, 2016
Last Update Posted : April 10, 2020
Information provided by (Responsible Party):
Yana Pikman, MD, Dana-Farber Cancer Institute

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : November 2021